SOLIGENIX, INC. cotiza a 0.33 USD y tiene una capitalización bursátil de $5M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (…
| Periodo | 2026-08 | 2026-05 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | $-0.13 | $-0.28 | $-0.58 | $-0.82 |
| Estimado | $-0.09 | $-0.24 | $-0.48 | $-1.05 |
| Sorpresa | -44.4% | -16.7% | -20.8% | +21.9% |
| Métrica | SNGX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -209.4% | -40.4% | -169.0% |
| ROA | -120.0% | -32.0% | -88.0% |
| Current Ratio | 2.39 | 2.84 | -0.45 |
| Debt / Equity | — | 0.28 | — |